UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

 

Date of Report (Date of earliest event reported) August 26, 2014

 

Kewaunee Scientific Corporation

 

(Exact name of registrant as specified in its charter)

     
Delaware 0-5286 38-0715562
(State or other jurisdiction
of incorporation)		 (Commission
File Number)		 (I.R.S. Employer
Identification No.)

 

2700 West Front Street

Statesville, North Carolina

(Address of principal executive offices)

 

28677

(Zip Code) 

 

Registrant’s telephone number, including area code    704-873-7202
 

N/A

 

(Former name or former address, if changed since last report.)

  

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 
 

Item 2.02      Results of Operations and Financial Condition

 

On August 26, 2014, Kewaunee Scientific Corporation issued a press release announcing its financial results for the first quarter ended July 31, 2014. A copy of the Press Release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

 

Item 9.01      Financial Statements and Exhibits

 

(d) Exhibits:

  

Exhibit No.

 

99.1 Press Release of Kewaunee Scientific Corporation dated August 26, 2014

 

In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

 

Signature

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

    (Registrant)
       Kewaunee Scientific Corporation
       
Date:  August 26, 2014      /s/ D. Michael Parker
       
     

D. Michael Parker

Senior Vice President, Finance

      Chief Financial Officer